Evidence map›Paper›PMID 42430107›Full record

ReviewBioresources and bioprocessing2026

Artificial intelligence and automation in enzyme engineering: evolution, advances, and future perspectives.

Kexin Hao, Jianguang Liu, Hui Tang, Yan Zhang, Yandong Sun, Hongyu Zhang, Ji Wang, Peng Liu, Jianmei Luo, Jing Zhao

Abstract readReview
In one paragraph

Review in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kexin Hao *State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, 306 Huiren Road, Tianjin, 300301, China.
Jianguang Liu *State Key Laboratory of Bio-based Fiber Materials, Key Laboratory of Industrial Fermentation Microbiology (Tianjin University of Science &Technology), Tianjin Key Laboratory of Industrial Microbiology, Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control, College of Biotechnology, Ministry of Education, Tianjin University of Science and Technology, Tianjin, 300457, China.
Hui Tang *State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, 306 Huiren Road, Tianjin, 300301, China.
Yan ZhangBeijing MegaRobo Technologies Co., Ltd, 901, 9th Floor, Block A, Longyu Center, No. 1 Yard, Longyuzhongjie, Huilongguan, Changping District, Beijing, 100085, China.
Yandong SunBeijing MegaRobo Technologies Co., Ltd, 901, 9th Floor, Block A, Longyu Center, No. 1 Yard, Longyuzhongjie, Huilongguan, Changping District, Beijing, 100085, China.
Hongyu ZhangBeijing MegaRobo Technologies Co., Ltd, 901, 9th Floor, Block A, Longyu Center, No. 1 Yard, Longyuzhongjie, Huilongguan, Changping District, Beijing, 100085, China.
Ji WangState Key Laboratory of Bio-based Fiber Materials, Key Laboratory of Industrial Fermentation Microbiology (Tianjin University of Science &Technology), Tianjin Key Laboratory of Industrial Microbiology, Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control, College of Biotechnology, Ministry of Education, Tianjin University of Science and Technology, Tianjin, 300457, China.
Peng LiuState Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, 306 Huiren Road, Tianjin, 300301, China. liup@tipr.com.cn.
Jianmei LuoState Key Laboratory of Bio-based Fiber Materials, Key Laboratory of Industrial Fermentation Microbiology (Tianjin University of Science &Technology), Tianjin Key Laboratory of Industrial Microbiology, Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control, College of Biotechnology, Ministry of Education, Tianjin University of Science and Technology, Tianjin, 300457, China. luojianmei@tust.edu.cn.
Jing ZhaoState Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, 306 Huiren Road, Tianjin, 300301, China. zhaojing@tipr.com.cn.ORCID http://orcid.org/0000-0002-0305-9791

Funding

Key Project of the Tianjin Natural Science Foundation 24JCZDJC00620National key Research and Development Program of International Cooperation Project 2023YFE0108100National Natural Science Foundation of China 32270135Tianjin Municipal Science and Technology Program 25ZXWCSY00130
6 · The paper itself

Abstract

Natural enzymes often fail to meet industrial demands for catalytic efficiency, stability, and substrate specificity, creating a critical bottleneck in biomanufacturing. This review examines how artificial intelligence (AI) and automation are reshaping enzyme engineering from empirical trial‑and‑error toward data-driven, closed-loop design. We trace AI development from feature-engineered machine learning to supervised deep learning and self-supervised protein language models, and automation from standalone task execution to cascade integration and biofoundry-enabled build-test workflows. Their convergence is analyzed through a stage-based autonomy framework, highlighting the transition from semi-automated workflows to conditional and high-autonomy DBTL systems. Recent studies demonstrate that AI-guided prediction, automated experimentation, and active learning can accelerate enzyme optimization; however, key barriers remain, including biased datasets, limited out-of-distribution generalization, weak mechanistic interpretability, automation interoperability constraints, and unresolved multi-objective trade-offs. We discuss future directions involving FAIR-compliant data infrastructure, hybrid sequence-structure-physics models, modular automation platforms, and autonomous closed-loop systems. By integrating historical evolution, representative case studies, success and failure analysis, and practical bottlenecks, this review provides a roadmap for advancing AI-guided and autonomous enzyme engineering.

Indexed as

Artificial intelligenceAutomation technologiesBiofoundryDesign-build-test-learn (DBTL) cycleEnzyme engineeringProtein language models

Identifiers

PMID42430107
PMCPMC13354739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.